These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

152 related items for PubMed ID: 3002388

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Inhibition of platelet aggregation by olive oil phenols via cAMP-phosphodiesterase.
    Dell'Agli M, Maschi O, Galli GV, Fagnani R, Dal Cero E, Caruso D, Bosisio E.
    Br J Nutr; 2008 May; 99(5):945-51. PubMed ID: 17927845
    [Abstract] [Full Text] [Related]

  • 26. 3,4-Dihydroquinolin-2(1H)-ones as combined inhibitors of thromboxane A2 synthase and cAMP phosphodiesterase.
    Martinez GR, Walker KA, Hirschfeld DR, Bruno JJ, Yang DS, Maloney PJ.
    J Med Chem; 1992 Feb 21; 35(4):620-8. PubMed ID: 1311763
    [Abstract] [Full Text] [Related]

  • 27. Regulation of cyclic AMP metabolism in human platelets. Sequential activation of adenylate cyclase and cyclic AMP phosphodiesterase by prostaglandins.
    Alvarez R, Taylor A, Fazzari JJ, Jacobs JR.
    Mol Pharmacol; 1981 Sep 21; 20(2):302-9. PubMed ID: 6272089
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Relative potencies of dipyridamole and related agents as inhibitors of cyclic nucleotide phosphodiesterases: possible explanation of mechansim of inhibition of platelet function.
    McElroy FA, Philip RB.
    Life Sci; 1975 Nov 01; 17(9):1479-93. PubMed ID: 173959
    [No Abstract] [Full Text] [Related]

  • 30. 1,3-Dihydro-2H-imidazo[4,5-b]quinolin-2-ones--inhibitors of blood platelet cAMP phosphodiesterase and induced aggregation.
    Meanwell NA, Roth HR, Smith EC, Wedding DL, Wright JJ, Fleming JS, Gillespie E.
    J Med Chem; 1991 Sep 01; 34(9):2906-16. PubMed ID: 1654430
    [Abstract] [Full Text] [Related]

  • 31. Interactions between prostaglandin E2 and inhibitors of platelet aggregation which act through cyclic AMP.
    Gray SJ, Heptinstall S.
    Eur J Pharmacol; 1991 Feb 26; 194(1):63-70. PubMed ID: 1647965
    [Abstract] [Full Text] [Related]

  • 32. Differential effects of phosphodiesterase inhibitors on platelet activating factor (PAF)- and adenosine diphosphate (ADP)-induced equine platelet aggregation.
    Rickards KJ, Andrews MJ, Waterworth TH, Alexander GB, Cunningham FM.
    J Vet Pharmacol Ther; 2003 Aug 26; 26(4):277-82. PubMed ID: 12887610
    [Abstract] [Full Text] [Related]

  • 33. Activation of cyclic GMP-binding and cyclic AMP-specific phosphodiesterases of rat platelets by a mechanism involving cyclic AMP-dependent phosphorylation.
    Tremblay J, Lachance B, Hamet P.
    J Cyclic Nucleotide Protein Phosphor Res; 1985 Aug 26; 10(4):397-411. PubMed ID: 2411769
    [Abstract] [Full Text] [Related]

  • 34. Synergistic antiplatelet effect of ridogrel, a combined thromboxane receptor antagonist and thromboxane synthase inhibitor, and UDCG-212, a cAMP-phosphodiesterase inhibitor.
    Hoet B, Arnout J, Deckmyn H, Vermylen J.
    Thromb Haemost; 1993 Nov 15; 70(5):822-5. PubMed ID: 8128441
    [Abstract] [Full Text] [Related]

  • 35. Inhibition of platelet aggregation and the release of P-selectin from platelets by cilostazol.
    Kariyazono H, Nakamura K, Shinkawa T, Yamaguchi T, Sakata R, Yamada K.
    Thromb Res; 2001 Mar 15; 101(6):445-53. PubMed ID: 11323002
    [Abstract] [Full Text] [Related]

  • 36. Immunological identification of the major platelet low-Km cAMP phosphodiesterase: probable target for anti-thrombotic agents.
    Macphee CH, Harrison SA, Beavo JA.
    Proc Natl Acad Sci U S A; 1986 Sep 15; 83(17):6660-3. PubMed ID: 3018742
    [Abstract] [Full Text] [Related]

  • 37. Decrease of platelet aggregation and spreading via inhibition of the cAMP phosphodiesterase by trapidil.
    Mazurov AV, Menshikov MYu, Leytin VL, Tkachuk VA, Repin VS.
    FEBS Lett; 1984 Jul 09; 172(2):167-71. PubMed ID: 6086387
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Inhibition of adenylate cyclase by adenosine analogues in preparations of broken and intact human platelets. Evidence for the unidirectional control of platelet function by cyclic AMP.
    Haslam RJ, Davidson MM, Desjardins JV.
    Biochem J; 1978 Oct 15; 176(1):83-95. PubMed ID: 215136
    [Abstract] [Full Text] [Related]

  • 40. Octimibate, a potent non-prostanoid inhibitor of platelet aggregation, acts via the prostacyclin receptor.
    Merritt JE, Hallam TJ, Brown AM, Boyfield I, Cooper DG, Hickey DM, Jaxa-Chamiec AA, Kaumann AJ, Keen M, Kelly E.
    Br J Pharmacol; 1991 Jan 15; 102(1):251-9. PubMed ID: 1710526
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.